ALLMedicine™ Cholangiocarcinoma Center
Research & Reviews 9,109 results
https://doi.org/10.1016/j.meddos.2021.01.003
Medical Dosimetry : Official Journal of the American Asso... Chuong MD, Kotecha R et. al.
Mar 2nd, 2021 - Stereotactic ablative body radiation therapy (SABR) is a well-established alternative to surgery for early stage non-small-cell lung cancer (NSCLC). While SABR is typically delivered in 3 to 5 fractions, randomized trials have shown single-fractio...
https://doi.org/10.1136/jclinpath-2020-207346
Journal of Clinical Pathology; Tavares I, Martins R et. al.
Mar 2nd, 2021 - Cholangiocarcinoma (CC) is a rare tumour arising from the biliary tract epithelium. The aim of this study was to perform a genomic characterisation of CC tumours and to implement a model to differentiate extrahepatic (ECC) and intrahepatic (ICC) c...
https://doi.org/10.1007/s00595-021-02249-x 10.1038/nrgastro.2011.131 10.1097/01.sla.0000251366.62632.d3 10.1097/SLA.0b013e3181afe0ab 10.1097/00000658-199912000-00010 10.1097/01.sla.0000160701.38945.82 10.1200/JCO.2009.22.3032 10.1097/MD.0000000000016764 10.1111/1759-7714.12556 10.1186/s12885-016-2510-z 10.5230/jgc.2012.12.2.81 10.3748/wjg.v24.i44.5046 10.1371/journal.pone.0146233 10.1159/000365477 10.1038/s41598-017-13934-8 10.1186/1471-2407-14-566 10.3748/wjg.v24.i13.1451 10.1007/s00268-017-3991-x 10.1016/j.ijsu.2019.03.022 10.21037/jgo.2019.09.11 10.1159/000355502 10.1097/MD.0000000000016974 10.2174/092986708783955455 10.1515/bchm3.1992.373.2.611 10.1016/S0049-3848(98)00165-0 10.1055/s-2007-991531 10.1111/j.1538-7836.2005.01365.x 10.1182/blood-2006-08-040956 10.1007/s00595-016-1339-z 10.3748/wjg.v22.i8.2601 10.1002/jso.25722 10.1097/SLA.0b013e318190a647 10.1002/cncr.20906 10.1046/j.1365-2168.2002.02211.x 10.1200/JCO.2009.22.4584 10.1111/j.1349-7006.2009.01115.x 10.1182/blood.V96.12.3772 10.1111/j.1538-7836.2007.02808.x
Surgery Today; Ye XW, Hu HJ et. al.
Mar 2nd, 2021 - Elevated fibrinogen (Fbg) levels contribute to tumor progression and metastasis. However, little is known regarding the association of the clinicopathological characteristics and the prognosis of hilar cholangiocarcinoma (HC) with plasma fibrinoge...
https://doi.org/10.1186/s12893-021-01094-6 10.1002/cncr.29692 10.1055/s-2004-828895 10.1016/j.suc.2010.04.011 10.1155/2015/860861 10.1016/j.cell.2010.01.025 10.1038/nature07205 10.1097/01.mco.0000165004.93707.88 10.7314/APJCP.2015.16.3.933 10.1158/1055-9965.EPI-14-0146 10.1371/journal.pone.0083069 10.1371/journal.pone.0101119 10.3109/10408363.2014.992064 10.1016/j.jacc.2007.02.067 10.1016/j.amjoto.2018.04.013 10.18632/oncotarget.13784 10.3233/CBM-160591 10.1097/MD.0000000000008056 10.1007/s10147-016-0986-9 10.1007/s13277-015-4774-3 10.21037/jtd.2016.12.44 10.3233/CBM-170032 10.1158/1078-0432.CCR-04-0713 10.3109/10408363.2014.992064 10.1515/cclm-2012-0795 10.4103/2229-5151.147518 10.1007/s00595-019-01933-3 10.21037/tau.2020.03.08 10.1038/s41598-020-57721-4 10.1515/cclm-2014-0699 10.7314/APJCP.2014.15.18.7781 10.1016/j.amjmed.2005.06.039 10.1016/j.cell.2011.02.013 10.1016/j.clnu.2010.03.001 10.1016/j.cca.2015.11.025 10.3325/cmj.2015.56.334 10.1007/s13277-015-4774-3 10.18632/oncotarget.9516 10.7150/jca.31598 10.1007/s10620-006-9164-7 10.1016/j.amjsurg.2007.02.024
BMC Surgery; Li X, Chen Q et. al.
Mar 2nd, 2021 - Recent studies suggest red blood cell distribution width (RDW) was a prognostic factor in various types of cancer patients, although the results are controversial. The objective of this study was to investigate the significance of RDW in patients ...
https://doi.org/10.1186/s13046-021-01890-1 10.1016/S0140-6736(13)61903-0 10.1038/nrclinonc.2017.157 10.1016/j.ebiom.2019.11.021 10.1200/JCO.2017.75.1586 10.1056/NEJMoa0908721 10.1093/annonc/mdv279 10.1016/j.bbrc.2014.02.050 10.1097/01.sla.0000251366.62632.d3 10.1016/j.ebiom.2019.06.023 10.1016/j.ebiom.2019.08.062 10.1038/nrc2271 10.1158/0008-5472.CAN-09-1212 10.1158/0008-5472.CAN-17-3045 10.1038/ncomms15008 10.1038/modpathol.2009.139 10.1093/nar/gkw205 10.1158/1078-0432.CCR-18-0517 10.1038/sj.bjc.6604883 10.1016/j.neo.2016.10.002 10.1002/mc.22671 10.1007/s00535-003-1221-9 10.1038/embor.2012.55 10.1038/s41586-018-0281-1 10.1186/s12935-018-0704-y 10.1111/jcmm.13833 10.1016/j.suronc.2016.12.003 10.1038/cr.2014.99 10.1016/j.biomaterials.2013.01.044 10.1074/mcp.M115.050401 10.18632/oncotarget.3355 10.1038/s41416-019-0633-0 10.1158/0008-5472.CAN-18-3987 10.1038/s41388-018-0485-8 10.3748/wjg.v21.i11.3256 10.1016/0092-8674(95)90052-7 10.1038/nrm.2016.8 10.2353/ajpath.2009.090069 10.1002/cbf.2876
Journal of Experimental & Clinical Cancer Research : CR; Li Z, Liu J et. al.
Mar 2nd, 2021 - Cholangiocarcinoma is a highly malignant cancer with very dismal prognosis. Perihilar cholangiocarcinoma(pCCA) accounts for more than 50% of all cholangiocarcinoma and is well-characterized for its low rate of radical resection. Effects of radioth...
Guidelines 15 results
https://doi.org/10.1016/j.cgh.2019.07.011
Clinical Gastroenterology and Hepatology : the Official C... Bowlus CL, Lim JK et. al.
Jul 15th, 2019 - The purpose of this clinical practice update is to define key principles in the surveillance of hepatobiliary cancers including cholangiocarcinoma, gallbladder adenocarcinoma, and hepatocellular carcinoma in patients with primary sclerosing cholan...
http://ascopubs.org/doi/full/10.1200/JCO.18.02178
Mar 10th, 2019 - PURPOSE To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with resected biliary tract cancer. METHODS ASCO convened an Expert Panel to conduct a systematic review of the literature on adju...
https://doi.org/10.1002/jhbp.596
Journal of Hepato-biliary-pancreatic Sciences; Kamisawa T, Nakazawa T et. al.
Dec 23rd, 2018 - IgG4-related sclerosing cholangitis (IgG4-SC) is a distinct type of cholangitis frequently associated with autoimmune pancreatitis and currently recognized as a biliary manifestation of IgG4-related disease. Although clinical diagnostic criteria o...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527854
HPB : the Official Journal of the International Hepato Pa... Mansour JC, Aloia TA et. al.
Jul 14th, 2015 - An American Hepato-Pancreato-Biliary Association (AHPBA)-sponsored consensus meeting of expert panellists met on 15 January 2014 to review current evidence on the management of hilar cholangiocarcinoma in order to establish practice guidelines and...
https://doi.org/10.1111/jgh.12128
Journal of Gastroenterology and Hepatology; Rerknimitr R, Angsuwatcharakon P et. al.
Jan 28th, 2013 - Hilar cholangiocarcinoma (HCCA) is one of the most common types of hepatobiliary cancers reported in the world including Asia-Pacific region. Early HCCA may be completely asymptomatic. When significant hilar obstruction develops, the patient prese...
Drugs 2 results see all →
Clinicaltrials.gov 9,279 results
https://doi.org/10.1016/j.meddos.2021.01.003
Medical Dosimetry : Official Journal of the American Asso... Chuong MD, Kotecha R et. al.
Mar 2nd, 2021 - Stereotactic ablative body radiation therapy (SABR) is a well-established alternative to surgery for early stage non-small-cell lung cancer (NSCLC). While SABR is typically delivered in 3 to 5 fractions, randomized trials have shown single-fractio...
https://doi.org/10.1136/jclinpath-2020-207346
Journal of Clinical Pathology; Tavares I, Martins R et. al.
Mar 2nd, 2021 - Cholangiocarcinoma (CC) is a rare tumour arising from the biliary tract epithelium. The aim of this study was to perform a genomic characterisation of CC tumours and to implement a model to differentiate extrahepatic (ECC) and intrahepatic (ICC) c...
https://doi.org/10.1007/s00595-021-02249-x 10.1038/nrgastro.2011.131 10.1097/01.sla.0000251366.62632.d3 10.1097/SLA.0b013e3181afe0ab 10.1097/00000658-199912000-00010 10.1097/01.sla.0000160701.38945.82 10.1200/JCO.2009.22.3032 10.1097/MD.0000000000016764 10.1111/1759-7714.12556 10.1186/s12885-016-2510-z 10.5230/jgc.2012.12.2.81 10.3748/wjg.v24.i44.5046 10.1371/journal.pone.0146233 10.1159/000365477 10.1038/s41598-017-13934-8 10.1186/1471-2407-14-566 10.3748/wjg.v24.i13.1451 10.1007/s00268-017-3991-x 10.1016/j.ijsu.2019.03.022 10.21037/jgo.2019.09.11 10.1159/000355502 10.1097/MD.0000000000016974 10.2174/092986708783955455 10.1515/bchm3.1992.373.2.611 10.1016/S0049-3848(98)00165-0 10.1055/s-2007-991531 10.1111/j.1538-7836.2005.01365.x 10.1182/blood-2006-08-040956 10.1007/s00595-016-1339-z 10.3748/wjg.v22.i8.2601 10.1002/jso.25722 10.1097/SLA.0b013e318190a647 10.1002/cncr.20906 10.1046/j.1365-2168.2002.02211.x 10.1200/JCO.2009.22.4584 10.1111/j.1349-7006.2009.01115.x 10.1182/blood.V96.12.3772 10.1111/j.1538-7836.2007.02808.x
Surgery Today; Ye XW, Hu HJ et. al.
Mar 2nd, 2021 - Elevated fibrinogen (Fbg) levels contribute to tumor progression and metastasis. However, little is known regarding the association of the clinicopathological characteristics and the prognosis of hilar cholangiocarcinoma (HC) with plasma fibrinoge...
https://doi.org/10.1186/s12893-021-01094-6 10.1002/cncr.29692 10.1055/s-2004-828895 10.1016/j.suc.2010.04.011 10.1155/2015/860861 10.1016/j.cell.2010.01.025 10.1038/nature07205 10.1097/01.mco.0000165004.93707.88 10.7314/APJCP.2015.16.3.933 10.1158/1055-9965.EPI-14-0146 10.1371/journal.pone.0083069 10.1371/journal.pone.0101119 10.3109/10408363.2014.992064 10.1016/j.jacc.2007.02.067 10.1016/j.amjoto.2018.04.013 10.18632/oncotarget.13784 10.3233/CBM-160591 10.1097/MD.0000000000008056 10.1007/s10147-016-0986-9 10.1007/s13277-015-4774-3 10.21037/jtd.2016.12.44 10.3233/CBM-170032 10.1158/1078-0432.CCR-04-0713 10.3109/10408363.2014.992064 10.1515/cclm-2012-0795 10.4103/2229-5151.147518 10.1007/s00595-019-01933-3 10.21037/tau.2020.03.08 10.1038/s41598-020-57721-4 10.1515/cclm-2014-0699 10.7314/APJCP.2014.15.18.7781 10.1016/j.amjmed.2005.06.039 10.1016/j.cell.2011.02.013 10.1016/j.clnu.2010.03.001 10.1016/j.cca.2015.11.025 10.3325/cmj.2015.56.334 10.1007/s13277-015-4774-3 10.18632/oncotarget.9516 10.7150/jca.31598 10.1007/s10620-006-9164-7 10.1016/j.amjsurg.2007.02.024
BMC Surgery; Li X, Chen Q et. al.
Mar 2nd, 2021 - Recent studies suggest red blood cell distribution width (RDW) was a prognostic factor in various types of cancer patients, although the results are controversial. The objective of this study was to investigate the significance of RDW in patients ...
https://doi.org/10.1186/s13046-021-01890-1 10.1016/S0140-6736(13)61903-0 10.1038/nrclinonc.2017.157 10.1016/j.ebiom.2019.11.021 10.1200/JCO.2017.75.1586 10.1056/NEJMoa0908721 10.1093/annonc/mdv279 10.1016/j.bbrc.2014.02.050 10.1097/01.sla.0000251366.62632.d3 10.1016/j.ebiom.2019.06.023 10.1016/j.ebiom.2019.08.062 10.1038/nrc2271 10.1158/0008-5472.CAN-09-1212 10.1158/0008-5472.CAN-17-3045 10.1038/ncomms15008 10.1038/modpathol.2009.139 10.1093/nar/gkw205 10.1158/1078-0432.CCR-18-0517 10.1038/sj.bjc.6604883 10.1016/j.neo.2016.10.002 10.1002/mc.22671 10.1007/s00535-003-1221-9 10.1038/embor.2012.55 10.1038/s41586-018-0281-1 10.1186/s12935-018-0704-y 10.1111/jcmm.13833 10.1016/j.suronc.2016.12.003 10.1038/cr.2014.99 10.1016/j.biomaterials.2013.01.044 10.1074/mcp.M115.050401 10.18632/oncotarget.3355 10.1038/s41416-019-0633-0 10.1158/0008-5472.CAN-18-3987 10.1038/s41388-018-0485-8 10.3748/wjg.v21.i11.3256 10.1016/0092-8674(95)90052-7 10.1038/nrm.2016.8 10.2353/ajpath.2009.090069 10.1002/cbf.2876
Journal of Experimental & Clinical Cancer Research : CR; Li Z, Liu J et. al.
Mar 2nd, 2021 - Cholangiocarcinoma is a highly malignant cancer with very dismal prognosis. Perihilar cholangiocarcinoma(pCCA) accounts for more than 50% of all cholangiocarcinoma and is well-characterized for its low rate of radical resection. Effects of radioth...
News 103 results
https://www.staging.medscape.com/viewarticle/928959
Apr 19th, 2020 - The US Food and Drug Administration (FDA) has granted accelerated approval of a new targeted therapy for use in some patients with cholangiocarcinoma, a rare cancer of the bile ducts. The product is pemigatinib (Pemazyre, Incyte), an oral kinase i...
https://www.medscape.com/viewarticle/928959
Apr 19th, 2020 - The US Food and Drug Administration (FDA) has granted accelerated approval of a new targeted therapy for use in some patients with cholangiocarcinoma, a rare cancer of the bile ducts. The product is pemigatinib (Pemazyre, Incyte), an oral kinase i...
https://reference.medscape.com/viewarticle/922403_1
Feb 19th, 2020 - Cancer of the bile duct, or cholangiocarcinoma, is a malignant neoplasm of the intrahepatic or extrahepatic biliary epithelium. It is the most common biliary tract cancer and the second most common primary hepatic cancer. Although its etiology is ...
https://reference.medscape.com/viewarticle/922403_2
Feb 19th, 2020 - Figure 1. Common bile duct and pancreatic duct Perihilar tumors, also called Klatskin tumors, are the most common cholangiocarcinomas. They occur in the hilum region at the bifurcation of the right and left hepatic ducts. Intrahepatic tumors are t...
https://reference.medscape.com/viewarticle/922398_3
Feb 19th, 2020 - Even though the rates of resection with tumor-free margins have improved with more aggressive surgical approaches and improved radiologic techniques, recurrence rates remain high (49%-64%). These recurrences usually occur within 2-3 years post-res...